1. Home
  2. EHTH vs NMRA Comparison

EHTH vs NMRA Comparison

Compare EHTH & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EHTH
  • NMRA
  • Stock Information
  • Founded
  • EHTH 1997
  • NMRA 2019
  • Country
  • EHTH United States
  • NMRA United States
  • Employees
  • EHTH N/A
  • NMRA N/A
  • Industry
  • EHTH Specialty Insurers
  • NMRA
  • Sector
  • EHTH Finance
  • NMRA
  • Exchange
  • EHTH Nasdaq
  • NMRA Nasdaq
  • Market Cap
  • EHTH 292.7M
  • NMRA 287.6M
  • IPO Year
  • EHTH 2006
  • NMRA 2023
  • Fundamental
  • Price
  • EHTH $7.34
  • NMRA $1.22
  • Analyst Decision
  • EHTH Hold
  • NMRA Buy
  • Analyst Count
  • EHTH 5
  • NMRA 8
  • Target Price
  • EHTH $7.70
  • NMRA $10.14
  • AVG Volume (30 Days)
  • EHTH 286.1K
  • NMRA 1.3M
  • Earning Date
  • EHTH 05-06-2025
  • NMRA 03-03-2025
  • Dividend Yield
  • EHTH N/A
  • NMRA N/A
  • EPS Growth
  • EHTH N/A
  • NMRA N/A
  • EPS
  • EHTH N/A
  • NMRA N/A
  • Revenue
  • EHTH $532,409,999.00
  • NMRA N/A
  • Revenue This Year
  • EHTH $1.50
  • NMRA N/A
  • Revenue Next Year
  • EHTH $8.74
  • NMRA N/A
  • P/E Ratio
  • EHTH N/A
  • NMRA N/A
  • Revenue Growth
  • EHTH 17.56
  • NMRA N/A
  • 52 Week Low
  • EHTH $3.58
  • NMRA $1.13
  • 52 Week High
  • EHTH $11.36
  • NMRA $17.19
  • Technical
  • Relative Strength Index (RSI)
  • EHTH 33.63
  • NMRA 28.26
  • Support Level
  • EHTH $7.71
  • NMRA $1.13
  • Resistance Level
  • EHTH $8.44
  • NMRA $1.48
  • Average True Range (ATR)
  • EHTH 0.49
  • NMRA 0.13
  • MACD
  • EHTH -0.12
  • NMRA 0.06
  • Stochastic Oscillator
  • EHTH 6.03
  • NMRA 18.04

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare and Employer and Individual. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

Share on Social Networks: